A US-based medical device manufacturer specializing in implanted devices sought Freyr's help to enhance device transparency by submitting UDI information to the GUDID database. Despite having US FDA Class I and Class II approvals, it was challenging for Freyr to determine appropriate GMDN codes, rectify data errors, and ensure timely ESG acknowledgments for seamless GUDID submission.

Discover how Freyr overcame these hurdles, offering complete Regulatory support for successful UDI implementation in the GUDID database. Learn about the client benefits in our downloadable case study.